Dr. med. Nina van Beek

1. van Beek N, Weidinger A, Schneider SW, Kleinheinz A, Gläser R, Holtsche MM, von Georg A, Hammers CM, Hübner F, Lima AL, Gola D, Sadik CD, Zillikens D, Katalinic A, Schmidt E, König IR. Incidence of pemphigoid diseases in Northern Germany in 2016 - first data from the Schleswig-Holstein Registry of Autoimmune Bullous Diseases. J Eur Acad Dermatol Venereol 2021 Jan 11. doi: 10.1111/jdv.17107. (Online ahead of print)

2. van Beek N, Krüger S, Fuhrmann T, Lemcke S, Goletz S, Probst C, Komorowski L, Di Zenzo G, Dmochowski M, Drenovska K, Horn M, Jedlickova H, Kowalewski C, Medenica L, Murrell D, Patsatsi A, Geller S, Uzun S, Vassileva S, Zhu X, Fechner K, Zillikens D, Stöcker W, Schmidt E, Rentzsch K. Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology. J Am Acad Dermatol 2020; 83:1315-1322

3. Russlies J, Fähnrich A, Witte M, Yin J, Benoit S, Gläser R, Günter C, Eming R, Erdmann J, Gola D, Gupta Y, Holtsche MM, Kern JS, König IR, Kiritsi D, Lieb W, Sadik CD, Sárdy M, Schauer F, van Beek N, Weidinger A, Worm M, Zillikens D, Schmidt E, Busch H, Ibrahim SM, Hirose M. Polymorphisms in the Mitochondrial Genome Are Associated With Bullous Pemphigoid in Germans. Front Immunol 2019; 10:2200

4. Holtsche MM, Goletz S, van Beek N, Zillikens D, Benoit S, Harman K, Walton S, English J, Sticherling M, Chapman A, Levell NJ, Groves R, Williams HC, König IR, Schmidt E; members of the BLISTER Study Group. Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score. Br J Dermatol 2018; 179:918-924

5. van Beek N, Dähnrich C, Johannsen N, Lemcke S, Goletz S, Hübner F, Di Zenzo G, Dmochowski M, Drenovska K, Geller S, Horn M, Kowalewski C, Medenica L, Murell DF, Patsatsi A, Uzun S, Vassileva S, Zillikens D, Schlumberger W, Schmidt E. Prospektive studies on routine use of a novel multivariant ELISA for the diagnosis of autoimmune bullous disease. J Am Acad Dermatol 2017; 76:889-894.e5

6. van Beek N, Lüttmann N, Huebner F, Recke A, Karl I, Schulze FS, Zillikens D, Schmidt E. Correlation of serum levels of IgE autoantibodies against BP180 with bullous pemphigoid disease activity. JAMA Dermatol 2017; 153:30-38

7. Williams HC, Wojnarowska F, Kirtschig G, Mason J, Godec TR, Schmidt E, Chalmers JR, Childs M, Walton S, Harman K, Chapman A, Whitham D, Nunn AJ; UK Dermatology Clinical Trials Network BLISTER Study Group: Adams J, Akhras V, Anstey A, Barnard C, Bell H, Blackford S, Bröcker E, Carmichael A, Coelho RR, Craig F, Davies K, Ellis R, English J, Gläser R, Groves R, Günthert C, Hampton PJ, Hepburn N, Hügel R, Hussain K, Ingram J, Layton AM, Levell NJ, Lewis V, Malhomme H, Omerod A, Patel G, Rallan R, Ravenscroft J, Santander H, Steinbrink K, Sticherling M, Thomas C, Vatve M, van Beek N, Venning V, Veysey E, Wachsmuth R, Wahie S, Walker B, Walsh M, Wee J, Westmoreland M, Wong G, Ferguson A, Verpetinske I, Duarte-Williamson E, Antony F, Bower C, Gawkrodger D, Taghipour K, Dunnill MGS, Waters A, Bottomley W, Wright A, Sterling J, Azam A, Gibbs S, Luger T, Salvary I, Lovell C, Ilchyshyn A, Gibbon K, Nik M, Charles-Holmes R, Lavery AL. Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial. Lancet 2017; 389:1630-1638

8. Sadik CD, Bischof J, van Beek N, Dieterich A, Benoit S, Sárdy M, Worm M, Meller S, Gläser R, Zillikens D, Homey B, Setterfield J, Minassian D, Schmidt E, Dart J; MMP study group 2009 - 2014; Autoimmune Bullous Diseases Study Group, Ibrahim SM. Genome-wide association study identifies GALC as susceptibility gene for mucous membrane pemphigoid. Exp Dermatol 2017; 97:128-130

9. Iwata H, Pipi E, Möckel N, Sondermann P, Vorobyev A, van Beek N, Zillikens D, Ludwig RJ. Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita. J Invest Dermatol. 2015; 135:916-9

10. van Beek N, Dohse A, Riechert F, Krull V, Recke A, Zillikens D, Schmidt E. Serum autoantibodies against the dermal-epidermal junction in patients with chronic pruritic disorders, elderly individuals and blood donors prospectively recruited. Br J Dermatol 2014; 170:943-7